Estudio del papel inmunomodulador de antígenos peptídicos provenientes de Mycobacterium Tuberculosis como herramienta en la búsqueda de una vacuna contra la Tuberculosis

Mycobacterium tuberculosis (Mtb) es el agente causal de la tuberculosis (TB), una enfermedad infecciosa que afecta las vías respiratorias1 . Se reporta que es la principal causa de muerte por un agente infeccioso 1, 2 . Actualmente, la vacuna BCG, única avalada por la OMS (Organización Mundial de la...

Full description

Autores:
Gamboa Hernández, Claudia Marcela
Tipo de recurso:
Trabajo de grado de pregrado
Fecha de publicación:
2021
Institución:
Colegio Mayor de Cundinamarca
Repositorio:
Repositorio Colegio Mayor de Cundinamarca
Idioma:
spa
OAI Identifier:
oai:repositorio.unicolmayor.edu.co:unicolmayor/2832
Acceso en línea:
https://repositorio.unicolmayor.edu.co/handle/unicolmayor/2832
Palabra clave:
Inmunomodulador
Enfermedad infecciosa
Agente infeccioso
Mycobacterium tuberculosis
Linfocitos T
Péptidos
Vacuna
Linajes linfocitarios
Tuberculosis
Rights
closedAccess
License
Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021
id UCOLMAYOR2_2a69f041f4c430b7e328d42189552f29
oai_identifier_str oai:repositorio.unicolmayor.edu.co:unicolmayor/2832
network_acronym_str UCOLMAYOR2
network_name_str Repositorio Colegio Mayor de Cundinamarca
repository_id_str
dc.title.spa.fl_str_mv Estudio del papel inmunomodulador de antígenos peptídicos provenientes de Mycobacterium Tuberculosis como herramienta en la búsqueda de una vacuna contra la Tuberculosis
title Estudio del papel inmunomodulador de antígenos peptídicos provenientes de Mycobacterium Tuberculosis como herramienta en la búsqueda de una vacuna contra la Tuberculosis
spellingShingle Estudio del papel inmunomodulador de antígenos peptídicos provenientes de Mycobacterium Tuberculosis como herramienta en la búsqueda de una vacuna contra la Tuberculosis
Inmunomodulador
Enfermedad infecciosa
Agente infeccioso
Mycobacterium tuberculosis
Linfocitos T
Péptidos
Vacuna
Linajes linfocitarios
Tuberculosis
title_short Estudio del papel inmunomodulador de antígenos peptídicos provenientes de Mycobacterium Tuberculosis como herramienta en la búsqueda de una vacuna contra la Tuberculosis
title_full Estudio del papel inmunomodulador de antígenos peptídicos provenientes de Mycobacterium Tuberculosis como herramienta en la búsqueda de una vacuna contra la Tuberculosis
title_fullStr Estudio del papel inmunomodulador de antígenos peptídicos provenientes de Mycobacterium Tuberculosis como herramienta en la búsqueda de una vacuna contra la Tuberculosis
title_full_unstemmed Estudio del papel inmunomodulador de antígenos peptídicos provenientes de Mycobacterium Tuberculosis como herramienta en la búsqueda de una vacuna contra la Tuberculosis
title_sort Estudio del papel inmunomodulador de antígenos peptídicos provenientes de Mycobacterium Tuberculosis como herramienta en la búsqueda de una vacuna contra la Tuberculosis
dc.creator.fl_str_mv Gamboa Hernández, Claudia Marcela
dc.contributor.advisor.none.fl_str_mv Sánchez Barinas, Christian David
Hernández Rojas, Edith
dc.contributor.author.none.fl_str_mv Gamboa Hernández, Claudia Marcela
dc.subject.lemb.none.fl_str_mv Inmunomodulador
Enfermedad infecciosa
Agente infeccioso
topic Inmunomodulador
Enfermedad infecciosa
Agente infeccioso
Mycobacterium tuberculosis
Linfocitos T
Péptidos
Vacuna
Linajes linfocitarios
Tuberculosis
dc.subject.proposal.spa.fl_str_mv Mycobacterium tuberculosis
Linfocitos T
Péptidos
Vacuna
Linajes linfocitarios
Tuberculosis
description Mycobacterium tuberculosis (Mtb) es el agente causal de la tuberculosis (TB), una enfermedad infecciosa que afecta las vías respiratorias1 . Se reporta que es la principal causa de muerte por un agente infeccioso 1, 2 . Actualmente, la vacuna BCG, única avalada por la OMS (Organización Mundial de la Salud) es utilizada para la prevención de las formas graves de TB en niños, pero su efectividad en adultos es variable1, 3. Por este motivo, en la Fundación Instituto de Inmunología de Colombia (FIDIC) se ha propuesto un modelo vacunal contra tuberculosis, basándose en la metodología lógica y racional empleada para la vacuna multiepitope sintética contra la malaria4, 5 . Se realizaron ensayos in silico para identificar el porcentaje de unión de 57 péptidos monoméricos (nativos y modificados) de Mtb a alelos DRβ1 del complejo mayor de histocompatibilidad tipo II (CMH II) de cada uno de los 18 donantes previamente genotipificados y clasificados por la prueba de diagnóstico PPD (purificate protein derivate). Luego, se desarrollaron ensayos in vitro de linfoproliferación; donde células mononucleares de sangre periférica (PBMCs), previamente marcadas con CFSE (Éster de succinimidil carboxifluoresceína) se estimularon con los péptidos de unión alelo/específica. Además, se evaluó el linaje de linfocitos T CD4 generados después de la estimulación con la identificación de factores de trascripción y citoquinas por métodos moleculares. Finalmente, se realizó la determinación del tipo de memoria inmunológica: centrales de memoria (CM), células madre de memoria (SCM) o efectoras de memoria (EM) mediante la identificación de moléculas de superficie (CD45RA, CD62L y CD45RO) características de estos tipos de células.
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2021-09-09T19:57:02Z
dc.date.available.none.fl_str_mv 2021-09-09T19:57:02Z
dc.date.issued.none.fl_str_mv 2021-05-20
dc.type.spa.fl_str_mv Trabajo de grado - Pregrado
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/bachelorThesis
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/TP
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_7a1f
status_str publishedVersion
dc.identifier.uri.none.fl_str_mv https://repositorio.unicolmayor.edu.co/handle/unicolmayor/2832
url https://repositorio.unicolmayor.edu.co/handle/unicolmayor/2832
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Organization WH. Global Tuberculosis Report. 2020.
Esmail H. BC, Young DB., Wilkinson RJ. The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond B Biol Sci. 2014;369(1645): 20130437.
Moliva JI. TJ, Torrelles JB. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? Vaccine. 2015;22; 33 (39):5035-41.
Curtidor H. RC, Bermúdez A., Vanegas M., Varela Y., Patarroyo ME. Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective. Molecules. 2017; 22:2199.
Patarroyo ME. CG, Vargas LE., Rosas J. Structural modifications enable conserved peptides to fit into MHC molecules thus inducing protection against malaria. Chembiochem Eur J Chem Biol. 2004;5:1588–1593.
Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. The Lancet. 1995;346(8986):1339-45.
Martino M. LL, Galli L. Immune Response to Mycobacterium tuberculosis: A Narrative Review. Front Pediatr. 2019.
Sánchez-Barinas C. OM, Tabares L., Bermúdez M., Patarroyo MA., Patarroyo ME. Specific Binding Peptides from Rv3632: A Strategy for Blocking Mycobacterium tuberculosis to Target Cells? . BioMed Research International. 2019;1–13.
Carabali-Isajar ML. OM, Rodríguez DC., Vanegas M., Curtidor H., Patarroyo MA., Patarroyo ME. Towards designing a synthetic antituberculosis vaccine: The Rv3587c peptide inhibits mycobacterial entry to host cells. Elservier. 2018;26 (9): 2401-2409.
Sánchez-Barinas CD. OM, Vanegas M. Mycobacterium tuberculosis H37Rv LpqG protein peptides can inhibit mycobacterial entry through specific interactions. Molecules. 2018;23(3).
Zhu J. YH, Paul W. Differentiation of Effector CD4 T Cell Populations. Annu Rev Immunol. 2010;28:445-89.
Sharma S. SM, Bose M. Mycobacterium tuberculosis infection of human monocyte-derived macrophages leads to apoptosis of T cells. Immunol Cell Biol. 2009;87(3):226-34.
Quah B. PC. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc. 2007;2(9):2049- 56.
Kieser KJ. RE. How sisters grow apart: mycobacteria growth and division. Nature Reviews Microbiology. 2014;12:550-62.
Nayak I. AB. Mantoux test and its interpretation. Indian Dermatol Online J. 2012;3(1): 2–6.
Danel C. KM, Inwoley A., Badje A., Herrmann J. Quantiferon-TB Gold: Performance for Ruling out Active Tuberculosis in HIV-Infected Adults with High CD4 Count in Côte d'Ivoire, West Africa. PLoS One. 2014;9(10): 107245.
Saeed M. AM, Iram S., Riaz S., Akhtaret M. GeneXpert technology: A breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than 2 hours. Saudi Med J. 2017;38(7): 699–705.
Sia JK. RJ. Immunology of Mycobacterium tuberculosis infections. Microbiol Spectr. 2019;7(4): 10.1128.
Kaufmann SH. HG, Lambert PH. New vaccines for tuberculosis. Lancet. 2010;375(9731):2110-9.
Bozzano F. MF, De Maria A. Immunology of tuberculosis. Mediterranean journal of hematology and infectious diseases. Mediterr J Hematol Infect Dis. 2014;6(1).
O'Garra A. RP, McNab FW., Bloom CI., Wilkinson RJ., Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475-527.
SH K. How can immunology contribute to the control of tuberculosis? Nature reviews Immunology. Nat Rev Immunol 2001;1(1):20-30.
Usman MM. IS, Teoh TC. Vaccine research and development: tuberculosis as a global health threat. Central-European journal of immunology. Cent Eur J Immunol. 2017;42(2): 196–204.
Zhu B. DH, Ottenhoff THM., Evans TG., Zhang Y. Tuberculosis vaccines: Opportunities and challenges. Respirology. 2018;23(4): 359–368.
Schrager LK. IA, Velmurugan K. Immunopathogenesis of tuberculosis and novel mechanisms of vaccine activity. Tuberculosis. 2016;1:S3-7.
Restrepo-Montoya D. VC, Niño LF., Ocampo M., Patarroyo ME., Patarroyo MA. Validating subcellular localization prediction tools with mycobacterial proteins. BMC Bioinformatics. 2009;10:134.
Vizcaino C. R-MD, Rodríguez D., Niño LF., Ocampo M. Computational Prediction and Experimental Assessment of Secreted/Surface Proteins from Mycobacterium tuberculosis H37Rv. PLoS Comput Biol. 2010;6 (6).
Cáceres SM. OM, Arévalo-Pinzón G., Jiménez RA., Patarroyo ME., Patarroyo MA. The Mycobacterium tuberculosis membrane protein Rv0180c: Evaluation of peptide sequences implicated in mycobacterial invasion of two human cell lines. Peptides. 2011;32(1):1-10.
Rodríguez DM. OM, Curtidor H., Vanegas M., Patarroyo ME., Patarroyo MA. Mycobacterium tuberculosis surface protein Rv0227c contains high activity binding peptides which inhibit cell invasion. Peptides. 2012;38(2):208-16.
Cifuentes DP. OM, Curtidor H., Vanegas M., Forero M., Patarroyo ME., Patarroyo MA. Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen. BMC microbiology BMC Microbiol. 2010;10:109.
Ocampo M. RD, Rodríguez J., Bermúdez M., Muñoz CM., Patarroyo MA., Patarroyo ME. Rv1268c protein peptide inhibiting Mycobacterium tuberculosis H37Rv entry to target cells. Bioorganic & medicinal chemistry. Bioorganic and Medicinal Chemistry 2013;6650-6656.
Ocampo M. CH, Vanegas M., Patarroyo MA., Patarroyo ME. Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro. Chem Biol Drug Des. 2014;84(6):626-41.
Patarroyo MA. CH, Plaza DF., Ocampo M., Reyes C., Saboya O., Barrera G., Patarroyo ME. Peptides derived from the Mycobacterium tuberculosis Rv1490 surface protein implicated in inhibition of epithelial cell entry: potential vaccine candidates? Vaccine. 2008;26(34):4387-95.
Rodríguez D. VC, Ocampo M. Peptides from the Mycobacterium tuberculosis Rv1980c protein involved in human cell infection: insights into new synthetic subunit vaccine candidates. Biol Chem. 2010;391(2-3):207-17.
Forero M. PA, Cortés J. Identifying putative Mycobacterium tuberculosis Rv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells. Protein Sci. 2005;14(11):2767-80.
Ocampo M. RD, Curtidor H., Vanegas M., Patarroyo MA., Patarroyo ME. Peptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages. Amino Acids. 2012;42(6):2067-77.
Plaza DF. CH, Patarroyo MA., Chapetón-Montes JA., Reyes C., Barreto J., Patarroyo ME. The Mycobacterium tuberculosis membrane protein Rv2560 biochemical and functional studies. FEBS J. 2007;274(24):6352-64.
Chapetón-Montes JA. PD, Curtidor H., Vanegas M., Forero M., Patarroyo ME., Patarroyo MA. Characterizing the Mycobacterium tuberculosis Rv2707 protein and determining its sequences which specifically bind to two human cell lines. Protein Sci. 2008;17(2): 342–351.
Ocampo M. A-RD, Rodríguez DM., Muñoz M., Curtidor H., Vanegas M., Patarroyo MA., Patarroyo ME. The role of Mycobacterium tuberculosis Rv3166c protein-derived high-activity binding peptides in inhibiting invasion of human cell lines. Protein Eng Des Sel. 2012;2012; 25(5):235-42.
Rodríguez D. OM, Varela Y., Curtidor H., Patarroyo MA., Patarroyo ME. Mce4F Mycobacterium tuberculosis protein peptides can inhibit invasion of human cell lines. Pathog Dis. 2015;73(3).
Ocampo M. PM, Vanegas M, Alba MP., Patarroyo ME.,. Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine. Crit Rev Microbiol. 2014;40(2):117-45.
Kaufmann E. SC, Battenfeld S., Paepe D., De Paepe D., Holzhauser T., Balks E., Homolka S., Reiling N., Gilleron M., Bastian M. BCG Vaccination Induces Robust CD4+ T Cell Responses to Mycobacterium tuberculosis Complex–Specific Lipopeptides in Guinea Pigs. J Immunol. 2016;196(6):2723-32.
Luckheeram RV. ZR, Verma AD., Xia B. CD4+T Cells: Differentiation and Functions. Clin Dev Immunol. 2012;2012:925135.
Muranski P. RN. Essentials of Th17 cell commitment and plasticity. Blood. 2013;121(13):2402-14.
Gattinoni L. RN. Moving T memory stem cells to the clinic. Blood. 2013;121(4):567.
Kirman JR H-TM, Agger EM. The Memory Immune Response to Tuberculosis. Microbiol Spectr. 2016;4(6).
Adigun R. SR. Tuberculosis. StatPearls. 2007.
(PAHO) PAHO. Tuberculosis. 2019.
Mert A. AF, Kuyucu T. Miliary tuberculosis. Medicine (Baltimore). 2017;96(5): e5875.
Hameed A. IM, Chhotaray C., Wang C., Liu Y., Tan Y., Li X.,. Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR- Mycobacterium tuberculosis Strains. Front Cell Infect Microbiol. 2018;10;8:114.
Salud INd. Boletin epidemiológico senanal: Semana epidemiológica 38. 20 al 26 de septiembre de 2020, Colombia. 2020.
Forrellad MA. KL, Gioffré A. Virulence factors of the Mycobacterium tuberculosis complex. Virulence. 2013;4(1): 3–66.
Maitra A. MT, HealyCell J. Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen. FEMS Microbiol Rev. 2019;43(5): 548–575.
Kaur I. GM, Skovierová H. Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis. Adv Appl Microbiol. 2009;69:23-78.
Porvaznik I. SI, Mokrý J.,. Non-Tuberculous Mycobacteria: Classification, Diagnostics, and Therapy. Adv Exp Med Biol. 2017;944:19-25.
Stamm CE CA, Shiloh MU. Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus. Immunol Rev. 2015;264(1): 204–219.
García JG. GJ, Antuña AS. Respiratory infections caused by environmental mycobacteria. 2005;41 (4): 206-19.
E. T. Microbiological Features and Clinical Relevance of New Species of the Genus Mycobacterium. Clin Microbiol Rev 2014;27(4): 727–752.
Percival S. WD. Mycobacterium. Microbiology of Waterborne Diseases. 2014;Second edition.
Davarpanah M. AD, Shojaei H.,. Prevalence and molecular characterization of non- tuberculous mycobacteria in hospital soil and dust of a developing country, Iran. Microbiology (Reading). 2019;165(12):1306-1314.
Alexander KA. LP, Michel AL. Novel Mycobacterium tuberculosis complex pathogen, M. mungi. Emerg Infect Dis. 2010;16:1296–9.
Van Ingen J. RZ, Mulder A. Characterization of Mycobacterium orygis as M. tuberculosis Complex Subspecies. Emerg Infect Dis. 2012;18(4): 653–655.
García S. A-MC, Campos-Bueno A. Diagnóstico microbiológico de la tuberculosis. 20 años en la provincia de Soria. Rendimiento y oportunidades básicas de mejora. Rev Esp Quimioter. 2018;31(2): 131–135.
Heemskerk D. CM, Marais B., Farrar J. Tuberculosis in Adults and Children. Chapter 4: Diagnosis. Springer. 2015.
Madhukar Pai 1 CMD, Sandra V Kik, Molebogeng X Rangaka, Alice Zwerling, Olivia Oxlade. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27(1):3-20.
Franco-Sotomayor G. R-OI, Leon-Benitez M., Uruchima-Campoverde S., Cardenas-Franco G., Perdomo-Castro M.,. Fast, Simple, and Cheap: the Kudoh-Ogawa Swab Method as an Alternative to the Petroff-Lowenstein-Jensen Method for Culturing of Mycobacterium tuberculosis. J Clin Microbiol. 2020;25;58(4):e01424-19.
Condalab. OADC Enrichment Supplement for the isolation and cultivation of Mycobacteria. In: Condalab, editor. Cat 60372019.
Campbell IA. B-SO. Pulmonary tuberculosis: diagnosis and treatment. BMJ. 2006;332(7551): 1194–1197.
Arteaga A. VME, Salazar Blanco OS. Clinical and sociodemographic characteristics of children, younger than 13 years, with or without a confirmed diagnosis of pulmonary tuberculosis, at Hospital Universitario San Vicente de Paúl, Medellín, Colombia, 2007-2008. Latreia. 2010;(23).
Agapito J. NV, Castro J., Accinelli R., Rodríguez I., Espinoza J.,. Caracterización de las mutaciones en el gen rpoβ asociadas a la rifampicina en pacientes con tuberculosis pulmonar. Rev perú med exp salud publica. 2002;19(3).
Wieczorek M. AE, Sticht J. . Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. . Front Immunol 2017;8:292.
Janeway CA. TP, Walport M. The major histocompatibility complex and its functions. Garland Science. 2001.
Oh J. SJ. Molecular mechanism and cellular function of MHCII ubiquitination. Immunol Rev. 2016.
DF. W. Mycobacterium tuberculosis metabolism. Cold Spring Harb Perspect Med. 2015;5(4):a021121.
Chai Q. ZY, Hua Liu C. Mycobacterium tuberculosis: An Adaptable Pathogen Associated With Multiple Human Diseases. Front Cell Infect Microbiol. 2018;8:158.
Heemskerk D. CM, Marais B., Farrar J. Tuberculosis in Adults and Children. Chapter 2: Pathogenesis. Springer. 2015.
Ferguson JS. WJ, Martin JL. et al. Complement Protein C3 Binding to Mycobacterium tuberculosis Is Initiated by the Classical Pathway in Human Bronchoalveolar Lavage Fluid. . Infect Immun. 2004;72(5): 2564–2573.
Yudhawati R. PN. The role of N-Acetyl Sistein in Pulmonary Tuberculosis. Department of Pulmonology and Respiratory Medicine. 2020;6(1).
Monin L GK, Slight S, Lin Y, Rangel-Moreno J, Khader SA. Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge. Mucosal Immunol. 2015;8:1099–109.
Lin PL FJ. CD8 T cells and Mycobacterium tuberculosis infection. . Semin Immunopathol. 2015;37:239–49.
Jacobs AJ. MJ, Screaton GR., McShane H. Antibodies and tuberculosis. Tuberculosis. 2016;101: 102-13.
Trinchieri G PS, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 2003;19(5):641–644.
Afkarian M SJ, Yang J. T-bet is a STATI-induced regulator for IL-12R expression in naïve CD4+ T cells. Nature Immunology. 2002;3(6):549–557.
Norman MU. ZL, Kubes P. . Interferon-gamma limits Th1 lymphocyte adhesion to inflamed endothelium: a nitric oxide regulatory feedback mechanism. Eur J Immunol. 2008;38(5):1368- 80.
Kaplan MH SU, Smiley ST, Grusby MJ. STAT6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 1996;4(3):313–319.
Braian C. HV, Stendahl O. Mycobacterium tuberculosis - Induced Neutrophil Extracellular Traps Activate Human Macrophages. J Innate Immun. 2013;5(6):591-602.
Parkash O. AS, Kumar M. T regulatory cells: Achilles’ heel of Mycobacterium tuberculosis infection? Immunol Res. 2015;62(3): 386-98.
S. C. Follicular helper CD4 T cells (TFH). . Annu Rev Immunol. 2011;29:621-63.
Quah B. PC. The Use of Carboxyfluorescein Diacetate Succinimidyl Ester (CFSE) to Monitor Lymphocyte Proliferation. J Vis Exp. 2010;(44): 2259.
Parish CR. GM, Quah B. . Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. . Curr Protoc Immunol. 2009;Chapter 4:Unit4.9.
Janeway CA Jr TP, Walport M. Immunobiology: The immune System in Health and Disease. . Garland Science. 2001;5th edition.
Farber DL. YN, Restifo NP. . Human memory T cells: generation, compartmentalization and homeostasis. . Nature Reviews Immunology 2014;(14) 24–35.
Poyntz HC. SE, Griffiths KL. Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Tuberculosis. 2014;94:226–237.
Yuan W. DN, Zhang L.,. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Vaccine. 2012;30:2490–2497.
Jensen KK. AM, Marcatili P., Buus S., Greenbaum JA., Yan Z., Sette A., Peters B., Nielsen M. Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology. 2018;154(3):394-406.
Merrifield RB. Solid phase peptide synthesis. i. the synthesis of a tetrapeptide. . Journal of the American Chemical Society. 1963;85(14):2149–2154.
Varela YF. VM, Patarroyo ME. . Synthetic Evaluation of Standard and Microwave-Assisted Solid Phase Peptide Synthesis of a Long Chimeric Peptide Derived from Four Plasmodium falciparum Proteins. . Molecules. 2018;23(11):2877.
Chirgwin JM. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. . Biochemistry. 1979;18, 5294–9.
Corporation P. Expression Analysis In: Protocols and Applications Promega Corporation. Guide. 2005;Online Edition.
Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. . Nucleic Acids Research. 2004;32(5):1792-1797.
Lehrach H. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical re-examination. Biochemistry. 1977;16, 4743–51.
McMaster GK. CG. Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci 1977;4835–8.
Patarroyo MA., Bermúdez A., López C., Yepes G, Patarroyo ME. 3D Analysis of the TCR/pMHCII Complex Formation in Monkeys Vaccinated with the First Peptide Inducing Sterilizing Immunity against Human Malaria. Plos one 2010.
dc.rights.spa.fl_str_mv Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/closedAccess
dc.rights.creativecommons.spa.fl_str_mv Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_14cb
rights_invalid_str_mv Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021
https://creativecommons.org/licenses/by-nc-sa/4.0/
Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
dc.format.extent.spa.fl_str_mv 104p.
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad Colegio Mayor de Cundinamarca
dc.publisher.faculty.spa.fl_str_mv Facultad de Ciencias de la Salud
dc.publisher.place.spa.fl_str_mv Bogotá D.C
dc.publisher.program.spa.fl_str_mv Bacteriología y Laboratorio Clínico
institution Colegio Mayor de Cundinamarca
bitstream.url.fl_str_mv https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/1/ClaudiaGamboa.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/2/FormatoDerechosAutor-Claudia%20Gamboa.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/3/Formato%20decanatura%202...pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/4/ClaudiaGamboa%20Informe%20final.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/5/license.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/6/ClaudiaGamboa.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/8/FormatoDerechosAutor-Claudia%20Gamboa.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/10/Formato%20decanatura%202...pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/7/ClaudiaGamboa.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/9/FormatoDerechosAutor-Claudia%20Gamboa.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/11/Formato%20decanatura%202...pdf.jpg
bitstream.checksum.fl_str_mv 9775cb566f243403706ae0d8a4a0b889
1376da3382f53b34e5a080d6335459af
af068557491b93193f4cc650c282d113
cfc7aec77c1d975806f8f7665325fedd
2f9959eaf5b71fae44bbf9ec84150c7a
aef309c5d1604022c446850af664ff6b
6863ab53eb90501e160d040b598fad61
68b329da9893e34099c7d8ad5cb9c940
cd980f973ef70e191efff16b3a353f0c
07bed2fe3cd56638cdae0a01fee19083
54b1611dc894295456cf9f541c17cb9a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital Unicolmayor
repository.mail.fl_str_mv repositorio@unicolmayor.edu.co
_version_ 1812210078836588544
spelling Sánchez Barinas, Christian David1620f45812be88f3aac5640594996576Hernández Rojas, Edithbb445075fe399249f42457b22b7525f9Gamboa Hernández, Claudia Marcela6bf655923ad231f83390f5860d99e1942021-09-09T19:57:02Z2021-09-09T19:57:02Z2021-05-20https://repositorio.unicolmayor.edu.co/handle/unicolmayor/2832Mycobacterium tuberculosis (Mtb) es el agente causal de la tuberculosis (TB), una enfermedad infecciosa que afecta las vías respiratorias1 . Se reporta que es la principal causa de muerte por un agente infeccioso 1, 2 . Actualmente, la vacuna BCG, única avalada por la OMS (Organización Mundial de la Salud) es utilizada para la prevención de las formas graves de TB en niños, pero su efectividad en adultos es variable1, 3. Por este motivo, en la Fundación Instituto de Inmunología de Colombia (FIDIC) se ha propuesto un modelo vacunal contra tuberculosis, basándose en la metodología lógica y racional empleada para la vacuna multiepitope sintética contra la malaria4, 5 . Se realizaron ensayos in silico para identificar el porcentaje de unión de 57 péptidos monoméricos (nativos y modificados) de Mtb a alelos DRβ1 del complejo mayor de histocompatibilidad tipo II (CMH II) de cada uno de los 18 donantes previamente genotipificados y clasificados por la prueba de diagnóstico PPD (purificate protein derivate). Luego, se desarrollaron ensayos in vitro de linfoproliferación; donde células mononucleares de sangre periférica (PBMCs), previamente marcadas con CFSE (Éster de succinimidil carboxifluoresceína) se estimularon con los péptidos de unión alelo/específica. Además, se evaluó el linaje de linfocitos T CD4 generados después de la estimulación con la identificación de factores de trascripción y citoquinas por métodos moleculares. Finalmente, se realizó la determinación del tipo de memoria inmunológica: centrales de memoria (CM), células madre de memoria (SCM) o efectoras de memoria (EM) mediante la identificación de moléculas de superficie (CD45RA, CD62L y CD45RO) características de estos tipos de células.Introducción 15 1. Planteamiento del problema 16 2. Justificación 17 3. Antecedentes 19 4. Objetivos 25 4.1 Objetivo general 25 4.2 Objetivos Específicos 25 3. Marco referencial 26 3.1 Generalidades de la tuberculosis 26 3.1.2 Epidemiología tuberculosis 26 3.1.2 Complejo Mycobacterium tuberculosis (MTB) 28 3.1.3 Diagnóstico de la tuberculosis 31 3.1.3.1 Criterio clínico: 31 3.1.3.2 Criterio microbiológico 31 3.1.3.3 Criterio radiológico 33 3.1.3.4 Criterio inmunológico 33 3.1.3.5 Pruebas moleculares 34 3.2 Presentación antigénica a través del CMH-II 35 3.3 Respuesta inmune contra Mtb 36 3.3 Linajes linfocitarios 39 3.4 Ensayo para la detección de la proliferación de linfocitos: Éster succinimidil de carboxifluoresceína (CFDASE) 42 3.5 Memoria Inmunológica 44 3.6 Modelos vacunales existentes 45 4. Diseño metodológico 47 4.1. Universo, población, muestra 47 4.2. Hipótesis, variables, indicadores. 47 4.3. Técnicas y procedimientos. 48 4.3.1 Selección de péptidos sintéticos 48 4.3.2 Análisis bioinformático de unión al CMH-II 49 4.3.3 Selección y clasificación de donantes 50 4.3.4 Síntesis de péptidos 51 4.3.5 Identificación de anticuerpos en plasma de los donantes 52 4.3.6 Ensayo de linfoproliferación 52 4.3.7 Identificación de linajes de linfocitos ayudadores 53 4.3.8 Evaluación de memoria inmunológica 56 5. Resultados 57 5.1 Análisis bioinformático de unión al CMH-II 57 5.2 Evaluación del reconocimiento de péptidos sintéticos provenientes de Mtb. 62 5.3 Determinación de la expansión clonal de linfocitos 64 5.4 Identificación de linajes de linfocitos T ayudadores 75 5.5 Evaluación de memoria inmunológica 78 6. Discusión 81 7. Conclusiones 84 Recomendaciones 85 Referencias bibliográficas 86 Anexos 91PregradoBacteriólogo(a) y Laboratorista Clínico104p.application/pdfspaUniversidad Colegio Mayor de CundinamarcaFacultad de Ciencias de la SaludBogotá D.CBacteriología y Laboratorio ClínicoDerechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021https://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/closedAccessAtribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)http://purl.org/coar/access_right/c_14cbEstudio del papel inmunomodulador de antígenos peptídicos provenientes de Mycobacterium Tuberculosis como herramienta en la búsqueda de una vacuna contra la TuberculosisTrabajo de grado - Pregradohttp://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/version/c_970fb48d4fbd8a85Textinfo:eu-repo/semantics/bachelorThesishttps://purl.org/redcol/resource_type/TPinfo:eu-repo/semantics/publishedVersionOrganization WH. Global Tuberculosis Report. 2020.Esmail H. BC, Young DB., Wilkinson RJ. The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond B Biol Sci. 2014;369(1645): 20130437.Moliva JI. TJ, Torrelles JB. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? Vaccine. 2015;22; 33 (39):5035-41.Curtidor H. RC, Bermúdez A., Vanegas M., Varela Y., Patarroyo ME. Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective. Molecules. 2017; 22:2199.Patarroyo ME. CG, Vargas LE., Rosas J. Structural modifications enable conserved peptides to fit into MHC molecules thus inducing protection against malaria. Chembiochem Eur J Chem Biol. 2004;5:1588–1593.Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. The Lancet. 1995;346(8986):1339-45.Martino M. LL, Galli L. Immune Response to Mycobacterium tuberculosis: A Narrative Review. Front Pediatr. 2019.Sánchez-Barinas C. OM, Tabares L., Bermúdez M., Patarroyo MA., Patarroyo ME. Specific Binding Peptides from Rv3632: A Strategy for Blocking Mycobacterium tuberculosis to Target Cells? . BioMed Research International. 2019;1–13.Carabali-Isajar ML. OM, Rodríguez DC., Vanegas M., Curtidor H., Patarroyo MA., Patarroyo ME. Towards designing a synthetic antituberculosis vaccine: The Rv3587c peptide inhibits mycobacterial entry to host cells. Elservier. 2018;26 (9): 2401-2409.Sánchez-Barinas CD. OM, Vanegas M. Mycobacterium tuberculosis H37Rv LpqG protein peptides can inhibit mycobacterial entry through specific interactions. Molecules. 2018;23(3).Zhu J. YH, Paul W. Differentiation of Effector CD4 T Cell Populations. Annu Rev Immunol. 2010;28:445-89.Sharma S. SM, Bose M. Mycobacterium tuberculosis infection of human monocyte-derived macrophages leads to apoptosis of T cells. Immunol Cell Biol. 2009;87(3):226-34.Quah B. PC. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc. 2007;2(9):2049- 56.Kieser KJ. RE. How sisters grow apart: mycobacteria growth and division. Nature Reviews Microbiology. 2014;12:550-62.Nayak I. AB. Mantoux test and its interpretation. Indian Dermatol Online J. 2012;3(1): 2–6.Danel C. KM, Inwoley A., Badje A., Herrmann J. Quantiferon-TB Gold: Performance for Ruling out Active Tuberculosis in HIV-Infected Adults with High CD4 Count in Côte d'Ivoire, West Africa. PLoS One. 2014;9(10): 107245.Saeed M. AM, Iram S., Riaz S., Akhtaret M. GeneXpert technology: A breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than 2 hours. Saudi Med J. 2017;38(7): 699–705.Sia JK. RJ. Immunology of Mycobacterium tuberculosis infections. Microbiol Spectr. 2019;7(4): 10.1128.Kaufmann SH. HG, Lambert PH. New vaccines for tuberculosis. Lancet. 2010;375(9731):2110-9.Bozzano F. MF, De Maria A. Immunology of tuberculosis. Mediterranean journal of hematology and infectious diseases. Mediterr J Hematol Infect Dis. 2014;6(1).O'Garra A. RP, McNab FW., Bloom CI., Wilkinson RJ., Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475-527.SH K. How can immunology contribute to the control of tuberculosis? Nature reviews Immunology. Nat Rev Immunol 2001;1(1):20-30.Usman MM. IS, Teoh TC. Vaccine research and development: tuberculosis as a global health threat. Central-European journal of immunology. Cent Eur J Immunol. 2017;42(2): 196–204.Zhu B. DH, Ottenhoff THM., Evans TG., Zhang Y. Tuberculosis vaccines: Opportunities and challenges. Respirology. 2018;23(4): 359–368.Schrager LK. IA, Velmurugan K. Immunopathogenesis of tuberculosis and novel mechanisms of vaccine activity. Tuberculosis. 2016;1:S3-7.Restrepo-Montoya D. VC, Niño LF., Ocampo M., Patarroyo ME., Patarroyo MA. Validating subcellular localization prediction tools with mycobacterial proteins. BMC Bioinformatics. 2009;10:134.Vizcaino C. R-MD, Rodríguez D., Niño LF., Ocampo M. Computational Prediction and Experimental Assessment of Secreted/Surface Proteins from Mycobacterium tuberculosis H37Rv. PLoS Comput Biol. 2010;6 (6).Cáceres SM. OM, Arévalo-Pinzón G., Jiménez RA., Patarroyo ME., Patarroyo MA. The Mycobacterium tuberculosis membrane protein Rv0180c: Evaluation of peptide sequences implicated in mycobacterial invasion of two human cell lines. Peptides. 2011;32(1):1-10.Rodríguez DM. OM, Curtidor H., Vanegas M., Patarroyo ME., Patarroyo MA. Mycobacterium tuberculosis surface protein Rv0227c contains high activity binding peptides which inhibit cell invasion. Peptides. 2012;38(2):208-16.Cifuentes DP. OM, Curtidor H., Vanegas M., Forero M., Patarroyo ME., Patarroyo MA. Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen. BMC microbiology BMC Microbiol. 2010;10:109.Ocampo M. RD, Rodríguez J., Bermúdez M., Muñoz CM., Patarroyo MA., Patarroyo ME. Rv1268c protein peptide inhibiting Mycobacterium tuberculosis H37Rv entry to target cells. Bioorganic & medicinal chemistry. Bioorganic and Medicinal Chemistry 2013;6650-6656.Ocampo M. CH, Vanegas M., Patarroyo MA., Patarroyo ME. Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro. Chem Biol Drug Des. 2014;84(6):626-41.Patarroyo MA. CH, Plaza DF., Ocampo M., Reyes C., Saboya O., Barrera G., Patarroyo ME. Peptides derived from the Mycobacterium tuberculosis Rv1490 surface protein implicated in inhibition of epithelial cell entry: potential vaccine candidates? Vaccine. 2008;26(34):4387-95.Rodríguez D. VC, Ocampo M. Peptides from the Mycobacterium tuberculosis Rv1980c protein involved in human cell infection: insights into new synthetic subunit vaccine candidates. Biol Chem. 2010;391(2-3):207-17.Forero M. PA, Cortés J. Identifying putative Mycobacterium tuberculosis Rv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells. Protein Sci. 2005;14(11):2767-80.Ocampo M. RD, Curtidor H., Vanegas M., Patarroyo MA., Patarroyo ME. Peptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages. Amino Acids. 2012;42(6):2067-77.Plaza DF. CH, Patarroyo MA., Chapetón-Montes JA., Reyes C., Barreto J., Patarroyo ME. The Mycobacterium tuberculosis membrane protein Rv2560 biochemical and functional studies. FEBS J. 2007;274(24):6352-64.Chapetón-Montes JA. PD, Curtidor H., Vanegas M., Forero M., Patarroyo ME., Patarroyo MA. Characterizing the Mycobacterium tuberculosis Rv2707 protein and determining its sequences which specifically bind to two human cell lines. Protein Sci. 2008;17(2): 342–351.Ocampo M. A-RD, Rodríguez DM., Muñoz M., Curtidor H., Vanegas M., Patarroyo MA., Patarroyo ME. The role of Mycobacterium tuberculosis Rv3166c protein-derived high-activity binding peptides in inhibiting invasion of human cell lines. Protein Eng Des Sel. 2012;2012; 25(5):235-42.Rodríguez D. OM, Varela Y., Curtidor H., Patarroyo MA., Patarroyo ME. Mce4F Mycobacterium tuberculosis protein peptides can inhibit invasion of human cell lines. Pathog Dis. 2015;73(3).Ocampo M. PM, Vanegas M, Alba MP., Patarroyo ME.,. Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine. Crit Rev Microbiol. 2014;40(2):117-45.Kaufmann E. SC, Battenfeld S., Paepe D., De Paepe D., Holzhauser T., Balks E., Homolka S., Reiling N., Gilleron M., Bastian M. BCG Vaccination Induces Robust CD4+ T Cell Responses to Mycobacterium tuberculosis Complex–Specific Lipopeptides in Guinea Pigs. J Immunol. 2016;196(6):2723-32.Luckheeram RV. ZR, Verma AD., Xia B. CD4+T Cells: Differentiation and Functions. Clin Dev Immunol. 2012;2012:925135.Muranski P. RN. Essentials of Th17 cell commitment and plasticity. Blood. 2013;121(13):2402-14.Gattinoni L. RN. Moving T memory stem cells to the clinic. Blood. 2013;121(4):567.Kirman JR H-TM, Agger EM. The Memory Immune Response to Tuberculosis. Microbiol Spectr. 2016;4(6).Adigun R. SR. Tuberculosis. StatPearls. 2007.(PAHO) PAHO. Tuberculosis. 2019.Mert A. AF, Kuyucu T. Miliary tuberculosis. Medicine (Baltimore). 2017;96(5): e5875.Hameed A. IM, Chhotaray C., Wang C., Liu Y., Tan Y., Li X.,. Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR- Mycobacterium tuberculosis Strains. Front Cell Infect Microbiol. 2018;10;8:114.Salud INd. Boletin epidemiológico senanal: Semana epidemiológica 38. 20 al 26 de septiembre de 2020, Colombia. 2020.Forrellad MA. KL, Gioffré A. Virulence factors of the Mycobacterium tuberculosis complex. Virulence. 2013;4(1): 3–66.Maitra A. MT, HealyCell J. Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen. FEMS Microbiol Rev. 2019;43(5): 548–575.Kaur I. GM, Skovierová H. Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis. Adv Appl Microbiol. 2009;69:23-78.Porvaznik I. SI, Mokrý J.,. Non-Tuberculous Mycobacteria: Classification, Diagnostics, and Therapy. Adv Exp Med Biol. 2017;944:19-25.Stamm CE CA, Shiloh MU. Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus. Immunol Rev. 2015;264(1): 204–219.García JG. GJ, Antuña AS. Respiratory infections caused by environmental mycobacteria. 2005;41 (4): 206-19.E. T. Microbiological Features and Clinical Relevance of New Species of the Genus Mycobacterium. Clin Microbiol Rev 2014;27(4): 727–752.Percival S. WD. Mycobacterium. Microbiology of Waterborne Diseases. 2014;Second edition.Davarpanah M. AD, Shojaei H.,. Prevalence and molecular characterization of non- tuberculous mycobacteria in hospital soil and dust of a developing country, Iran. Microbiology (Reading). 2019;165(12):1306-1314.Alexander KA. LP, Michel AL. Novel Mycobacterium tuberculosis complex pathogen, M. mungi. Emerg Infect Dis. 2010;16:1296–9.Van Ingen J. RZ, Mulder A. Characterization of Mycobacterium orygis as M. tuberculosis Complex Subspecies. Emerg Infect Dis. 2012;18(4): 653–655.García S. A-MC, Campos-Bueno A. Diagnóstico microbiológico de la tuberculosis. 20 años en la provincia de Soria. Rendimiento y oportunidades básicas de mejora. Rev Esp Quimioter. 2018;31(2): 131–135.Heemskerk D. CM, Marais B., Farrar J. Tuberculosis in Adults and Children. Chapter 4: Diagnosis. Springer. 2015.Madhukar Pai 1 CMD, Sandra V Kik, Molebogeng X Rangaka, Alice Zwerling, Olivia Oxlade. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27(1):3-20.Franco-Sotomayor G. R-OI, Leon-Benitez M., Uruchima-Campoverde S., Cardenas-Franco G., Perdomo-Castro M.,. Fast, Simple, and Cheap: the Kudoh-Ogawa Swab Method as an Alternative to the Petroff-Lowenstein-Jensen Method for Culturing of Mycobacterium tuberculosis. J Clin Microbiol. 2020;25;58(4):e01424-19.Condalab. OADC Enrichment Supplement for the isolation and cultivation of Mycobacteria. In: Condalab, editor. Cat 60372019.Campbell IA. B-SO. Pulmonary tuberculosis: diagnosis and treatment. BMJ. 2006;332(7551): 1194–1197.Arteaga A. VME, Salazar Blanco OS. Clinical and sociodemographic characteristics of children, younger than 13 years, with or without a confirmed diagnosis of pulmonary tuberculosis, at Hospital Universitario San Vicente de Paúl, Medellín, Colombia, 2007-2008. Latreia. 2010;(23).Agapito J. NV, Castro J., Accinelli R., Rodríguez I., Espinoza J.,. Caracterización de las mutaciones en el gen rpoβ asociadas a la rifampicina en pacientes con tuberculosis pulmonar. Rev perú med exp salud publica. 2002;19(3).Wieczorek M. AE, Sticht J. . Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. . Front Immunol 2017;8:292.Janeway CA. TP, Walport M. The major histocompatibility complex and its functions. Garland Science. 2001.Oh J. SJ. Molecular mechanism and cellular function of MHCII ubiquitination. Immunol Rev. 2016.DF. W. Mycobacterium tuberculosis metabolism. Cold Spring Harb Perspect Med. 2015;5(4):a021121.Chai Q. ZY, Hua Liu C. Mycobacterium tuberculosis: An Adaptable Pathogen Associated With Multiple Human Diseases. Front Cell Infect Microbiol. 2018;8:158.Heemskerk D. CM, Marais B., Farrar J. Tuberculosis in Adults and Children. Chapter 2: Pathogenesis. Springer. 2015.Ferguson JS. WJ, Martin JL. et al. Complement Protein C3 Binding to Mycobacterium tuberculosis Is Initiated by the Classical Pathway in Human Bronchoalveolar Lavage Fluid. . Infect Immun. 2004;72(5): 2564–2573.Yudhawati R. PN. The role of N-Acetyl Sistein in Pulmonary Tuberculosis. Department of Pulmonology and Respiratory Medicine. 2020;6(1).Monin L GK, Slight S, Lin Y, Rangel-Moreno J, Khader SA. Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge. Mucosal Immunol. 2015;8:1099–109.Lin PL FJ. CD8 T cells and Mycobacterium tuberculosis infection. . Semin Immunopathol. 2015;37:239–49.Jacobs AJ. MJ, Screaton GR., McShane H. Antibodies and tuberculosis. Tuberculosis. 2016;101: 102-13.Trinchieri G PS, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 2003;19(5):641–644.Afkarian M SJ, Yang J. T-bet is a STATI-induced regulator for IL-12R expression in naïve CD4+ T cells. Nature Immunology. 2002;3(6):549–557.Norman MU. ZL, Kubes P. . Interferon-gamma limits Th1 lymphocyte adhesion to inflamed endothelium: a nitric oxide regulatory feedback mechanism. Eur J Immunol. 2008;38(5):1368- 80.Kaplan MH SU, Smiley ST, Grusby MJ. STAT6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 1996;4(3):313–319.Braian C. HV, Stendahl O. Mycobacterium tuberculosis - Induced Neutrophil Extracellular Traps Activate Human Macrophages. J Innate Immun. 2013;5(6):591-602.Parkash O. AS, Kumar M. T regulatory cells: Achilles’ heel of Mycobacterium tuberculosis infection? Immunol Res. 2015;62(3): 386-98.S. C. Follicular helper CD4 T cells (TFH). . Annu Rev Immunol. 2011;29:621-63.Quah B. PC. The Use of Carboxyfluorescein Diacetate Succinimidyl Ester (CFSE) to Monitor Lymphocyte Proliferation. J Vis Exp. 2010;(44): 2259.Parish CR. GM, Quah B. . Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. . Curr Protoc Immunol. 2009;Chapter 4:Unit4.9.Janeway CA Jr TP, Walport M. Immunobiology: The immune System in Health and Disease. . Garland Science. 2001;5th edition.Farber DL. YN, Restifo NP. . Human memory T cells: generation, compartmentalization and homeostasis. . Nature Reviews Immunology 2014;(14) 24–35.Poyntz HC. SE, Griffiths KL. Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Tuberculosis. 2014;94:226–237.Yuan W. DN, Zhang L.,. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Vaccine. 2012;30:2490–2497.Jensen KK. AM, Marcatili P., Buus S., Greenbaum JA., Yan Z., Sette A., Peters B., Nielsen M. Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology. 2018;154(3):394-406.Merrifield RB. Solid phase peptide synthesis. i. the synthesis of a tetrapeptide. . Journal of the American Chemical Society. 1963;85(14):2149–2154.Varela YF. VM, Patarroyo ME. . Synthetic Evaluation of Standard and Microwave-Assisted Solid Phase Peptide Synthesis of a Long Chimeric Peptide Derived from Four Plasmodium falciparum Proteins. . Molecules. 2018;23(11):2877.Chirgwin JM. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. . Biochemistry. 1979;18, 5294–9.Corporation P. Expression Analysis In: Protocols and Applications Promega Corporation. Guide. 2005;Online Edition.Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. . Nucleic Acids Research. 2004;32(5):1792-1797.Lehrach H. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical re-examination. Biochemistry. 1977;16, 4743–51.McMaster GK. CG. Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci 1977;4835–8.Patarroyo MA., Bermúdez A., López C., Yepes G, Patarroyo ME. 3D Analysis of the TCR/pMHCII Complex Formation in Monkeys Vaccinated with the First Peptide Inducing Sterilizing Immunity against Human Malaria. Plos one 2010.InmunomoduladorEnfermedad infecciosaAgente infecciosoMycobacterium tuberculosisLinfocitos TPéptidosVacunaLinajes linfocitariosTuberculosisORIGINALClaudiaGamboa.pdfClaudiaGamboa.pdfapplication/pdf1849915https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/1/ClaudiaGamboa.pdf9775cb566f243403706ae0d8a4a0b889MD51open accessFormatoDerechosAutor-Claudia Gamboa.pdfFormatoDerechosAutor-Claudia Gamboa.pdfapplication/pdf453192https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/2/FormatoDerechosAutor-Claudia%20Gamboa.pdf1376da3382f53b34e5a080d6335459afMD52metadata only accessFormato decanatura 2...pdfFormato decanatura 2...pdfapplication/pdf80538https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/3/Formato%20decanatura%202...pdfaf068557491b93193f4cc650c282d113MD53metadata only accessClaudiaGamboa Informe final.pdfClaudiaGamboa Informe final.pdfapplication/pdf9437184https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/4/ClaudiaGamboa%20Informe%20final.pdfcfc7aec77c1d975806f8f7665325feddMD54open accessLICENSElicense.txtlicense.txttext/plain; charset=utf-814828https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/5/license.txt2f9959eaf5b71fae44bbf9ec84150c7aMD55open accessTEXTClaudiaGamboa.pdf.txtClaudiaGamboa.pdf.txtExtracted texttext/plain13953https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/6/ClaudiaGamboa.pdf.txtaef309c5d1604022c446850af664ff6bMD56open accessFormatoDerechosAutor-Claudia Gamboa.pdf.txtFormatoDerechosAutor-Claudia Gamboa.pdf.txtExtracted texttext/plain1982https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/8/FormatoDerechosAutor-Claudia%20Gamboa.pdf.txt6863ab53eb90501e160d040b598fad61MD58metadata only accessFormato decanatura 2...pdf.txtFormato decanatura 2...pdf.txtExtracted texttext/plain1https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/10/Formato%20decanatura%202...pdf.txt68b329da9893e34099c7d8ad5cb9c940MD510metadata only accessTHUMBNAILClaudiaGamboa.pdf.jpgClaudiaGamboa.pdf.jpgGenerated Thumbnailimage/jpeg5622https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/7/ClaudiaGamboa.pdf.jpgcd980f973ef70e191efff16b3a353f0cMD57open accessFormatoDerechosAutor-Claudia Gamboa.pdf.jpgFormatoDerechosAutor-Claudia Gamboa.pdf.jpgGenerated Thumbnailimage/jpeg12531https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/9/FormatoDerechosAutor-Claudia%20Gamboa.pdf.jpg07bed2fe3cd56638cdae0a01fee19083MD59metadata only accessFormato decanatura 2...pdf.jpgFormato decanatura 2...pdf.jpgGenerated Thumbnailimage/jpeg9385https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2832/11/Formato%20decanatura%202...pdf.jpg54b1611dc894295456cf9f541c17cb9aMD511metadata only accessunicolmayor/2832oai:repositorio.unicolmayor.edu.co:unicolmayor/28322024-04-29 17:54:04.201An error occurred on the license name.|||https://creativecommons.org/licenses/by-nc-sa/4.0/open accessBiblioteca Digital Unicolmayorrepositorio@unicolmayor.edu.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

Publicaciones similares